Daniel Hommes

Daniel Hommes has a diverse work experience spanning various roles and organizations. Daniel is currently serving as the Chief Medical Officer and previously as the VP of Clinical Development at InterVenn Biosciences, a leader in glycoprotein analysis and biomarker research. Before that, they held the position of Chief Executive Officer and Board Member at DEARhealth, a company specializing in AI-powered Care Pathways for improved health outcomes. In addition, Daniel Hommes has held academic positions as a Professor at Leiden University Medical Center and UCLA Health System, where they focused on research and development in the field of healthcare innovation and applied artificial intelligence. Daniel has also contributed their expertise as the President of ECCO European Crohn's and Colitis Organisation and the Initiative on Crohn and Colitis (ICC). Throughout their career, Daniel Hommes has demonstrated a strong commitment to advancing patient care in the field of inflammatory bowel diseases and has made significant contributions to the development of guidelines and therapies in this area.

Daniel Hommes has a diverse education history. Daniel obtained an MD degree in Internal Medicine - Gastroenterology from the University of Amsterdam, where they studied from 1994 to 2001. Prior to that, they also earned an MD degree in Medicine from the same university, studying from 1985 to 1990. Daniel further expanded their medical knowledge by completing a Clinical Epidemiology program at McMaster University in 1988. In the early years of their education, they studied Medicine at Ghent University from 1983 to 1985. Additionally, Daniel attended Het Nieuwe Lyceum in Hilversum, although the dates and degree obtained are not specified.